Semi-micro column high-performance liquid chromatography with UV detection for quantification of aspirin and salicylic acid and its application to patients' sera administered with low-dose enteric-coated aspirin

Biomedical Chromatography

Volumn 21, Issue 3, 2007, Pages 221-224

  Ohwaki, Yuichi ^a   Yamane, Tomoko ^a   Ishimatsu, Takashi ^b   Wada, Mitsuhiro ^a   Nakashima, Kenichiro ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b Caritas Sotome Clinic   (Japan)

Author keywords

Aspirin; Human serum; Salicylic acid; Semi micro column HPLC

Indexed keywords

BODY FLUIDS; COLUMN CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHASE SEPARATION; SIGNAL TO NOISE RATIO;

ASPIRIN; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HPLC-UV; HUMAN SERUM; ITS APPLICATIONS; LOW DOSE; MICRO-COLUMNS; SEMI-MICRO COLUMN HPLC; SIMULTANEOUS DETERMINATIONS; UV DETECTION;

SALICYLIC ACID;

ACETYLSALICYLIC ACID; PHOSPHORIC ACID; SALICYLIC ACID;

ACCURACY; ADULT; AGED; ARTICLE; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; ENTERIC COATED TABLET; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LOW DRUG DOSE; MALE; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; SIGNAL NOISE RATIO; SOLID PHASE EXTRACTION; ULTRAVIOLET SPECTROSCOPY;

EID: 33947610423     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.742     Document Type: Article

References (24)

1. Abu-Qare AW and Abou-Donia MB. A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine. Journal of Pharmaceutical and Biomedical Analysis 2001; 26: 939.
2. Bogentoft C, Carlsson I, Ekenved G and Magnusson A. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms. European Journal of Clinical Pharmacology 1978; 14: 351.
3. Cryer B and Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999; 117: 17.
4. Derry S and Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. British Medical Journal 2000; 321: 1183.
5. Feldman M, Cryer B, Mallat D and Go MF. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial. American Journal of Gastroenterology 2001; 96: 1751.
6. Franeta JT, Agbaba D, Eric S, Pavkov S, Aleksic M and Vladimirov S. HPLC assay of acetylsalicylic acid, paracetamol, caffeine and phenobarbital in tablets. Farmaco 2002; 57: 709.
7. Gandhimathi M, Ravi TK, Abraham A and Thomas R. Simultaneous determination of aspirin and isosorbide 5-mononitrate in formulation by reversed phase high pressure liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 2003; 32: 1145.
8. Graham DY and Smith JL. Aspirin and the stomach. Annals of Internal Medicine 1986; 104: 390.
9. He J, Whelton PK, Vu B and Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998; 280: 1930.
10. Hoftiezer JW, Burks M, Silvoso GR and Ivey KJ. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 1980; 316: 609.
11. Kees F, Jehnich D and Grobecker H. Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by high-performance liquid chromatography. Journal of Chromatography B 1996; 677: 172.
12. Lanza FL, Royer GL and Nelson RS. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. New England Journal of Medicine 1980; 303: 136.
13. McMahon GP, O'Connor SJ, Fitzgerald DJ, Roy S and Kelly MT. Determination of aspirin and salicylic acid in transdermal perfusates. Journal of Chromatography B 1998; 707: 322.
14. Ohwaki Y, Miyazaki C, Yamagata K, Tahara T, Inohira T, Hamada T, Nakashima MN, Wada M and Nakashima K. Aspirin therapy for the primary prevention of cardiovascular disease: a meta-analysis of randomized trials. Japanese Journal of Pharmaceutical Health Care Science 2004; 30: 789.
15. Pirola R, Bareggi SR and De Benedittis G. Determination of acetylsalicylic acid and salicylic acid in skin and plasma by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Science Applications 1998; 705: 309.
16. Roberts MS, McLeod LJ, Cossum PA and Vial JH. Inhibition of platelet function by a controlled release acetylsalicylic acid formulation - single and chronic dosing studies. European Journal of Clinical Pharmacology 1984; 27: 67.
17. Roderick PJ, Wilkes HC and Meade TW. The gastrointestinal toxicity of aspirin: an overview of randomized controlled trials. British Journal of Clinical Pharmacology 1993; 35: 219.
18. Ross-Lee LM, Elms MJ, Cham BE, Bochner F, Bunce IH and Eadie MJ. Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function. European Journal of Clinical Pharmacology 1982; 23: 545.
19. Schoen RT and Vender RJ. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. American Journal of Medicine 1989; 86: 449.
20. Stalnikowicz-Darvasi R. Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events: a critical analysis. Journal of Clinical Gastroenterology 1995; 21: 13.
21. Tagliaro F, Cuzzolin L, Adami A, Scarcella D, Crivellente F and Benoni G. Pharmacokinetics of a new nitroderivative of acetylsalicylic acid after a single dose in rats. Life Science 1997; 60: 101.
22. Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, Rawlins M, Vessey M and Wainwright P. Prophylactic aspirin and risk of peptic ulcer bleeding. British Medical Journal 1995; 310: 827.
23. Weisman SM and Graham DY. Evaluation of benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular events. Archives of Internal Medicine 2002; 162: 2197.
24. Wolfe MM, Lichtenstein DR and Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. New England Journal of Medicine 1999; 340: 1888.